Targeting Gene-ViroTherapy for prostate cancer by DD3-driven oncolytic virus-harboring interleukin-24 gene

被引：36
作者：
Fan, Jun Kai [1 ]
Wei, Na [1 ]
Ding, Miao [1 ]
Gu, Jin Fa [1 ]
Liu, Xin Ran [1 ]
Li, Bing Hua [1 ]
Qi, Rong [1 ]
Huang, Wei Dan [1 ]
Li, Yu Hua [2 ]
Xiong, Xiao Quan [3 ]
Wang, Jian [2 ]
Li, Run Sheng [2 ]
Liu, Xin Yuan [1 ,4 ]
机构：
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China
[2] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China
[3] Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada
[4] Zhejiang Sci Tech Univ, Coll Biol Sci, Xinyuan Inst Med & Biotechnol, Hangzhou, Zhejiang, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CANCER | 2010年 / 127卷 / 03期
关键词：
DD3; IL-24; oncolytic adenovirus; apoptosis; prostate cancer; DIFFERENTIATION-ASSOCIATED GENE-7; MELANOMA-DIFFERENTIATION; REPLICATING ADENOVIRUS; TUMOR-CELLS; MDA-7/IL-24; THERAPY; GROWTH; CARCINOMA; MDA-7; EXPRESSION;
D O I：
10.1002/ijc.25069
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Prostate cancer (PCa) is the second leading cause of cancer-related deaths in Western male population. Previous studies have demonstrated that differential display code 3 (DD3 or DD3(PCA3)) is one of the most PCa-specific genes; therefore, it has been used as a clinical diagnostic marker for PCa. In this study, we constructed an oncolytic adenovirus Ad.DD3-E1A by using the minimal DD3 promoter to replace the native viral promoter of E1A gene. In addition, Ad.DD3-E1A was armed with therapeutic gene IL-24 to enhance its antitumor activity. The resulting adenovirus, Ad.DD3-E1A-IL-24, demonstrated PCa specificity and excellent antitumor effect. Further analyses on its antitumor mechanism revealed that it has the capacity to induce apoptosis in PCa cells and inhibit angiogenesis. These results suggest that Ad.DD3-E1A-IL-24 is a promising antitumor agent that may be able to be used in the future as a treatment for PCa.
引用
收藏
页码：707 / 717
页数：11
相关论文
共 36 条
[1]   Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death [J].
Abou El Hassan, MAI ;
van der Meulen-Muileman, I ;
Abbas, S ;
Kruyt, FAE .
JOURNAL OF VIROLOGY, 2004, 78 (22) :12243-12251
[2]   Tumorigenesis and the angiogenic switch [J].
Bergers, G ;
Benjamin, LE .
NATURE REVIEWS CANCER, 2003, 3 (06) :401-410
[3]  
Bialkowska-Hobrzanska Hanna, 2006, Can J Urol, V13, P2967
[4]   The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24 [J].
Caudell, EG ;
Mumm, JB ;
Poindexter, N ;
Ekmekcioglu, S ;
Mhashilkar, AM ;
Yang, XHH ;
Retter, MW ;
Hill, P ;
Chada, S ;
Grimm, EA .
JOURNAL OF IMMUNOLOGY, 2002, 168 (12) :6041-6046
[5]   Clinical and local biological effects of an intraturnoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma:: a phase I study [J].
Cunningham, CC ;
Chada, S ;
Merritt, JA ;
Tong, A ;
Senzer, N ;
Zhang, Y ;
Mhashilkar, A ;
Parker, K ;
Vukelja, S ;
Richards, D ;
Hood, J ;
Coffee, K ;
Nemunaitis, J .
MOLECULAR THERAPY, 2005, 11 (01) :149-159
[6]  
de Kok JB, 2002, CANCER RES, V62, P2695
[7]   Development of prostate cancer treatment: The good news [J].
Denmeade, SR ;
Isaacs, JT .
PROSTATE, 2004, 58 (03) :211-224
[8]   MDA-7/IL-24 regulates proliferation, invasion and tumor cell radiosensitivity: A new cancer therapy? [J].
Dent, P ;
Yacoub, A ;
Grant, S ;
Curiel, DT ;
Fisher, PB .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 95 (04) :712-719
[9]  
Fisher PB, 2003, CANCER BIOL THER, V2, pS23
[10]   mda-7/IL-24:: Multifunctional cancer-specific apoptosis-inducing cytokine [J].
Gupta, Pankaj ;
Su, Zao-zhong ;
Lebedeva, Irina V. ;
Sarkar, Devanand ;
Sauane, Moira ;
Emdad, Luni ;
Bachelor, Michael A. ;
Grant, Steven ;
Curiel, David T. ;
Dent, Paul ;
Fisher, Paul B. .
PHARMACOLOGY & THERAPEUTICS, 2006, 111 (03) :596-628
1234